Shuzhen Liu, Lei He, Yang Yuan, Guangzhi Wang, Wenhua Qin
{"title":"Genkwanin通过激活sirt1介导的Nrf2/HO-1信号通路减轻百草枯诱导的急性肺损伤。","authors":"Shuzhen Liu, Lei He, Yang Yuan, Guangzhi Wang, Wenhua Qin","doi":"10.1007/s00210-025-04685-9","DOIUrl":null,"url":null,"abstract":"<p><p>Paraquat (PQ) mainly damages the lungs, leading to acute lung injury (ALI) and even pulmonary fibrosis. Genkwanin (GEN) is demonstrated to possess anti-inflammatory and antioxidant activities in several diseases. This study aims to elucidate the protective effect of GEN against PQ-induced ALI and to decipher its underlying molecular mechanism. C57BL/6 J mice were injected intraperitoneally with 20 mg/kg PQ to induce an in vivo ALI model. BEAS-2B cells were treated with PQ to mimic an in vitro ALI model. The results showed that GEN alleviated PQ-induced lung pathologic damage, lung injury score, wet/dry weight ratio, myeloperoxidase (MPO) activity, and inflammatory cytokine production. GEN inhibited the expression of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) and enhanced the activities of superoxide dismutase (SOD) and catalase (CAT) in lung tissues of PQ-treated mice. Also, GEN decreased PQ-induced apoptosis of lung tissues by downregulating Bax and Cleaved caspase 3 and elevating Bcl-2. Moreover, GEN repressed inflammatory factor levels, reactive oxygen species (ROS) production, and apoptosis in PQ-stimulated BEAS-2B cells. Additionally, GEN treatment led to the increase of sirtuin 1 (SIRT1) expression in both PQ-treated mice and BEAS-2B cells. Inhibition of SIRT1 largely reversed the inhibitory effects of GEN on PQ-induced inflammation, oxidative stress, and apoptosis in mice and cells. Furthermore, GEN activated the Nrf2/HO-1 signaling by upregulating SIRT1 in mice and BEAS-2B cells administered with PQ. In conclusion, GEN ameliorates lung inflammation, oxidative stress, and apoptosis in PQ-induced ALI by inducing SIRT1 to activate the Nrf2/HO-1 signaling. Our findings highlight the potential of GEN to resist PQ poisoning.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genkwanin alleviates paraquat-induced acute lung injury by activating SIRT1-mediated Nrf2/HO-1 signaling pathway.\",\"authors\":\"Shuzhen Liu, Lei He, Yang Yuan, Guangzhi Wang, Wenhua Qin\",\"doi\":\"10.1007/s00210-025-04685-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Paraquat (PQ) mainly damages the lungs, leading to acute lung injury (ALI) and even pulmonary fibrosis. Genkwanin (GEN) is demonstrated to possess anti-inflammatory and antioxidant activities in several diseases. This study aims to elucidate the protective effect of GEN against PQ-induced ALI and to decipher its underlying molecular mechanism. C57BL/6 J mice were injected intraperitoneally with 20 mg/kg PQ to induce an in vivo ALI model. BEAS-2B cells were treated with PQ to mimic an in vitro ALI model. The results showed that GEN alleviated PQ-induced lung pathologic damage, lung injury score, wet/dry weight ratio, myeloperoxidase (MPO) activity, and inflammatory cytokine production. GEN inhibited the expression of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) and enhanced the activities of superoxide dismutase (SOD) and catalase (CAT) in lung tissues of PQ-treated mice. Also, GEN decreased PQ-induced apoptosis of lung tissues by downregulating Bax and Cleaved caspase 3 and elevating Bcl-2. Moreover, GEN repressed inflammatory factor levels, reactive oxygen species (ROS) production, and apoptosis in PQ-stimulated BEAS-2B cells. Additionally, GEN treatment led to the increase of sirtuin 1 (SIRT1) expression in both PQ-treated mice and BEAS-2B cells. Inhibition of SIRT1 largely reversed the inhibitory effects of GEN on PQ-induced inflammation, oxidative stress, and apoptosis in mice and cells. Furthermore, GEN activated the Nrf2/HO-1 signaling by upregulating SIRT1 in mice and BEAS-2B cells administered with PQ. In conclusion, GEN ameliorates lung inflammation, oxidative stress, and apoptosis in PQ-induced ALI by inducing SIRT1 to activate the Nrf2/HO-1 signaling. Our findings highlight the potential of GEN to resist PQ poisoning.</p>\",\"PeriodicalId\":18876,\"journal\":{\"name\":\"Naunyn-Schmiedeberg's archives of pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Naunyn-Schmiedeberg's archives of pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00210-025-04685-9\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-04685-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Paraquat (PQ) mainly damages the lungs, leading to acute lung injury (ALI) and even pulmonary fibrosis. Genkwanin (GEN) is demonstrated to possess anti-inflammatory and antioxidant activities in several diseases. This study aims to elucidate the protective effect of GEN against PQ-induced ALI and to decipher its underlying molecular mechanism. C57BL/6 J mice were injected intraperitoneally with 20 mg/kg PQ to induce an in vivo ALI model. BEAS-2B cells were treated with PQ to mimic an in vitro ALI model. The results showed that GEN alleviated PQ-induced lung pathologic damage, lung injury score, wet/dry weight ratio, myeloperoxidase (MPO) activity, and inflammatory cytokine production. GEN inhibited the expression of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) and enhanced the activities of superoxide dismutase (SOD) and catalase (CAT) in lung tissues of PQ-treated mice. Also, GEN decreased PQ-induced apoptosis of lung tissues by downregulating Bax and Cleaved caspase 3 and elevating Bcl-2. Moreover, GEN repressed inflammatory factor levels, reactive oxygen species (ROS) production, and apoptosis in PQ-stimulated BEAS-2B cells. Additionally, GEN treatment led to the increase of sirtuin 1 (SIRT1) expression in both PQ-treated mice and BEAS-2B cells. Inhibition of SIRT1 largely reversed the inhibitory effects of GEN on PQ-induced inflammation, oxidative stress, and apoptosis in mice and cells. Furthermore, GEN activated the Nrf2/HO-1 signaling by upregulating SIRT1 in mice and BEAS-2B cells administered with PQ. In conclusion, GEN ameliorates lung inflammation, oxidative stress, and apoptosis in PQ-induced ALI by inducing SIRT1 to activate the Nrf2/HO-1 signaling. Our findings highlight the potential of GEN to resist PQ poisoning.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.